Lv1
10 积分 2024-10-21 加入
Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
2小时前
已完结
Exploring the therapeutic potential of ADC combination for triple-negative breast cancer
3天前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
4天前
已完结
Generating an In Vitro Gut Model with Physiologically Relevant Biophysical Mucus Properties
27天前
已完结
皖公网安备34019202002308
